BIM
INSM icon

Bridges Investment Management’s Insmed INSM Stock Holding History

Bridges Investment Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,081
Closed -$362K – 403
2025
Q4 		$362K Buy
2,081
+544
+35% +$99.3K ﹤0.01% 329
2025
Q3 		$221K Buy
+1,537
New +$188K ﹤0.01% 394

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bridges Investment Management's INSM Position: Q1 2026 in Review

Bridges Investment Management sold out of Insmed (INSM) in Q1 2026, closing a stake of 2,081 shares — an estimated $362K sold.

Bridges Investment Management first reported a position in INSM in Q3 2025 and held it in 2 quarters. The position peaked at $362K in Q4 2025. 673 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Bridges Investment Management reported no remaining Insmed position as of Q1 2026 after selling out during the quarter.
  • Bridges Investment Management sold 2,081 Insmed shares in Q1 2026, an estimated $362K.
  • Bridges Investment Management first reported a position in Insmed in Q3 2025 and held it in 2 quarters.
  • Bridges Investment Management's Insmed position peaked at $362K in Q4 2025.
  • 673 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Bridges Investment Management's 13F filing for Q1 2026, filed 4 May 2026.